Records containing: Retinal Degeneration
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-05A Phase III b, Multicenter Study of the Efficacy and Safety of Aflibercept Switch in Patients With Exudative AMD With Detachment of the Retinal Pigment Epithelium and Previously Treated With Ranibizumab Intravitreal Injection. (ARI2)
-
CLINICAL_TRIALS study record update · 2026-04-24Generation of Induced Pluripotent Stem (iPS) Cell Lines From Somatic Cells of Participants With Eye Diseases and From Somatic Cells of Matched Controls
-
CLINICAL_TRIALS study record update · 2026-04-24Natural History of ABCA4-Related Retinopathies
-
CLINICAL_TRIALS study record update · 2026-04-20Oral Metformin for Treatment of ABCA4 Retinopathy
-
CLINICAL_TRIALS study record update · 2026-04-20Rod and Cone Mediated Function in Retinal Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1/2a Study of Subretinal Administration of OpCT-001 Photoreceptor Precursor Cells Derived From iPSCs in Patients With Primary Photoreceptor Disease
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1 Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy
-
CLINICAL_TRIALS study record update · 2026-03-31A First-In-Human, Open Label, Dose Escalation Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Dose of AXV-101 in Patients With Bardet-Biedl Syndrome 1 (BBS1) Bi-Allelic Mutations and Retinal Degeneration
-
CLINICAL_TRIALS study record update · 2026-02-23Effectiveness of TMS for Visual Restoration: a Multicenter Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-02-04Rate of Progression of PCDH15-Related Retinal Degeneration in Usher
-
CLINICAL_TRIALS study record update · 2025-12-18Efficacy of Dapagliflozin in the Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
-
CLINICAL_TRIALS study record update · 2025-12-02A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 (30 μg and 75 μg) Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 in the PLATYPUS Study (Protocol # VP001-101) or WALLABY Study (Protocol # VP001-102) for a Minimum of 8 Weeks
-
CLINICAL_TRIALS study record update · 2025-11-18High Resolution and High Speed Multimodal Ophthalmic Imaging
-
CLINICAL_TRIALS study record update · 2025-08-24FOCUS: An Open Label First in Human Phase I/II Multicentre Study to Evaluate the Safety, Dose Response and Efficacy of GT005 Administered as a Single Subretinal Injection in Subjects With Macular Atrophy Due to AMD
-
CLINICAL_TRIALS study record update · 2025-08-05A Phase 2b, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With Diabetic Macular Edema
-
CLINICAL_TRIALS study record update · 2025-06-13A Multicentre, Natural History, Non-interventional Study Evaluating Biomarkers In Participants With Geographic Atrophy(GA) Secondary To Age-Related Macular Degeneration (AMD)
-
CLINICAL_TRIALS study record update · 2025-06-06Randomized, Double-blind, Parallel, Active Controlled Study to Compare Efficacy & Safety Between Ranibizumab 10mg/ml Injection of Incepta and Lucentis in Patients With Diabetic Macular Edema by ITV Injection
-
CLINICAL_TRIALS study record update · 2025-06-06Assessing the Modulation of Retinal Atrophy and Neurofilament Light Chain by Ofatumumab in Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-04-30An Open-label, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IVB102 Injection in Subjects With X-linked Retinoschisis (XLRS)
-
CLINICAL_TRIALS study record update · 2025-04-03Adaptive Optics Imaging of Outer Retinal Diseases
-
CLINICAL_TRIALS study record update · 2025-03-25A Long-Term Follow-Up Study in Subjects Who Received an Adeno-Associated Viral Vector Serotype 2 Containing the Multi-Characteristic Opsin Gene (vMCO-I) Administered Via Intravitreal Injection
-
CLINICAL_TRIALS study record update · 2025-03-24Long Term Follow-up for Subjects Who Previously Participated in the NTXMCO-002 RESTORE Study
-
CLINICAL_TRIALS study record update · 2024-11-26Brain-Computer Interface (BCI) and Evaluation of Visual and Task Performance in Subjects With Eye Diseases
-
CLINICAL_TRIALS study record update · 2024-10-30A Study of Disease Progression in Genetically Defined Subjects With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
-
CLINICAL_TRIALS study record update · 2024-08-21Performance of Optimized Long-wavelength Fundus Autofluorescence Imaging in Patients With Retinal Diseases